TITLE

Future use of the Glasgow alcoholic hepatitis score

AUTHOR(S)
Guha, I. N.; Rosenberg, W. M.
PUB. DATE
January 2006
SOURCE
Gut;Jan2006, Vol. 55 Issue 1, p135
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to an article related to future use of the Glasgow alcoholic hepatitis score, which was published in a 2005 issue.
ACCESSION #
19623608

 

Related Articles

  • Letters to the editor. Kazuaki Inoue; Makoto Yoshiba // Journal of Gastroenterology;Sep2005, Vol. 40 Issue 9, p912 

    Presents a response to a letter to the editor about possible prevention of fulminant hepatic failure in four children with acute severe hepatitis.

  • Letters to the editor. Raffaele Iorio; Spagnuolo, Maria Immacolata // Journal of Gastroenterology;Sep2005, Vol. 40 Issue 9, p912 

    Presents a response to a letter to the editor about possible prevention of fulminant hepatic failure in four children with acute severe hepatitis.

  • Combination Therapy for Hepatitis C Infection. Newman, Thomas B. // New England Journal of Medicine;04/15/99, Vol. 340 Issue 15, p1207 

    A letter to the editor is presented in response to two articles about combination therapy for hepatitis C infection by McHutchison et al. and by Davis et al. in the November 19, 1998 issue.

  • Combination Therapy for Hepatitis C Infection. Clay, Christina M. // New England Journal of Medicine;04/15/99, Vol. 340 Issue 15, p1207 

    A letter to the editor is presented in response to two articles about combination therapy for hepatitis C infection by McHutchison et al. and by Davis et al. in the November 19, 1998 issue.

  • Combination Therapy for Hepatitis C Infection. Davis, Gary L.; McHutchison, John G. // New England Journal of Medicine;04/15/99, Vol. 340 Issue 15, p1207 

    A letter to the editor is presented in response to two articles about combination therapy for hepatitis C infection by McHutchison et al. and by Davis et al. in the November 19, 1998 issue.

  • Combination Therapy for Hepatitis C Infection. Liang, T. Jake // New England Journal of Medicine;04/15/99, Vol. 340 Issue 15, p1207 

    A letter to the editor is presented in response to two articles about combination therapy for hepatitis C infection by McHutchison et al. and by Davis et al. in the November 19, 1998 issue.

  • Lamivudine for the Treatment of Chronic Hepatitis B. Verhelst, David; Goffin, Eric // New England Journal of Medicine;02/24/2000, Vol. 342 Issue 8, p592 

    A letter to the editor is presented in response to an article focusing on the treatment of chronic Hepatitis B, by J.L. Dienstag and others in the October 21, 1999 issue.

  • Lamivudine for the Treatment of Chronic Hepatitis B. Dienstag, Jules L.; Brown, Nathaniel A.; Woessner, Mary // New England Journal of Medicine;02/24/2000, Vol. 342 Issue 8, p592 

    A response by Jules L. Dienstag, Nathaniel A. Brown and Mary Woessner to a letter to the editor about their article focusing on the treatment of chronic Hepatitis in the October 21, 1999 issue is presented.

  • IN RESPONSE. Henry L. Y. Chan; Joseph J. Y. Sung // Annals of Internal Medicine;9/6/2005, Vol. 143 Issue 5, p391 

    Presents a response from authors to a letter to the editor on their article about pegylated interferon in patients with hepatitis B, published previously in the journal "Annals of Internal Medicine."

  • Cost-Effectiveness in Hepatitis B. Weitzman, Gil; Jacobson, Ira // Annals of Internal Medicine;11/15/2005, Vol. 143 Issue 10, p757 

    Presents a letter to the editor about cost-effectiveness in Hepatitis B.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics